首页> 美国卫生研究院文献>other >A Versatile Microparticle-Based Immunoaggregation Assay for Macromolecular Biomarker Detection and Quantification
【2h】

A Versatile Microparticle-Based Immunoaggregation Assay for Macromolecular Biomarker Detection and Quantification

机译:基于大分子生物标志物检测和定量的基于多功能微粒的免疫聚集测定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The rapid, sensitive and low-cost detection of macromolecular biomarkers is critical in clinical diagnostics, environmental monitoring, research, etc. Conventional assay methods usually require bulky, expensive and designated instruments and relative long assay time. For hospitals and laboratories that lack immediate access to analytical instruments, fast and low-cost assay methods for the detection of macromolecular biomarkers are urgently needed. In this work, we developed a versatile microparticle (MP)-based immunoaggregation method for the detection and quantification of macromolecular biomarkers. Antibodies (Abs) were firstly conjugated to MP through streptavidin-biotin interaction; the addition of macromolecular biomarkers caused the aggregation of Ab-MPs, which were subsequently detected by an optical microscope or optical particle sizer. The invisible nanometer-scale macromolecular biomarkers caused detectable change of micrometer-scale particle size distributions. Goat anti-rabbit immunoglobulin and human ferritin were used as model biomarkers to demonstrate MP-based immunoaggregation assay in PBS and 10% FBS to mimic real biomarker assay in the complex medium. It was found that both the number ratio and the volume ratio of Ab-MP aggregates caused by biomarker to all particles were directly correlated to the biomarker concentration. In addition, we found that the detection range could be tuned by adjusting the Ab-MP concentration. We envision that this novel MP-based immunoaggregation assay can be combined with multiple detection methods to detect and quantify macromolecular biomarkers at the nanogram per milliliter level.
机译:快速,灵敏和低成本的大分子生物标志物检测在临床诊断,环境监测,研究等方面至关重要。常规测定方法通常需要笨重,昂贵且指定的仪器,并且测定时间相对较长。对于缺乏立即使用分析仪器的医院和实验室,迫切需要快速且低成本的检测方法来检测大分子生物标志物。在这项工作中,我们开发了一种基于通用微粒(MP)的免疫聚集方法,用于检测和定量大分子生物标志物。首先通过链霉亲和素-生物素相互作用将抗体(Abs)与MP结合;大分子生物标志物的添加导致Ab-MP的聚集,随后通过光学显微镜或光学粒度仪对其进行检测。看不见的纳米级大分子生物标记物引起了微米级粒度分布的可检测变化。山羊抗兔免疫球蛋白和人类铁蛋白被用作模型生物标志物,以证明在PBS和10%FBS中基于MP的免疫聚集测定,以模拟复杂培养基中的真实生物标记物测定。已经发现,由生物标志物引起的Ab-MP聚集体与所有颗粒的数量比和体积比均与生物标志物浓度直接相关。此外,我们发现可以通过调节Ab-MP浓度来调整检测范围。我们设想,这种新颖的基于MP的免疫聚集测定可以与多种检测方法结合起来,以纳克每毫升的水平检测和定量大分子生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号